Astrana Total Assets from 2010 to 2026

ASTH Stock

21.96 0.36 1.61%

Astrana Health's Total Assets are increasing with slightly volatile movements from year to year. Total Assets are estimated to finish at about 1.6 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2001-09-30

Previous Quarter

1.4 B

Current Value

2.2 B

Quarterly Volatility

498.7 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 40 M, Other Operating Expenses of 2.3 B or Operating Income of 107.9 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0029 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.

Build AI portfolio with Astrana Stock

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

The Total Assets trend for Astrana Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Astrana Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Astrana Health's Total Assets Growth Pattern

Below is the plot of the Total Assets of Astrana Health over the last few years. Total assets refers to the total amount of Astrana Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Astrana Health books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Astrana Health's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.35 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Astrana Total Assets Regression Statistics

	Arithmetic Mean	584,093,575
	Geometric Mean	69,853,627
	Coefficient Of Variation	99.48
	Mean Deviation	492,875,530
	Median	512,999,049
	Standard Deviation	581,030,536
	Sample Variance	337596.5T
	Range	1.6B
	R-Value	0.96
	Mean Square Error	30438.6T
	R-Squared	0.92
	Slope	110,090,925
	Total Sum of Squares	5401543.7T

Astrana Total Assets History

	2026	1.6 B
	2025	1.6 B
	2024	1.4 B
	2023	933.4 M
	2022	966.2 M
	2021	867.4 M
	2020	817.5 M

Other Fundumenentals of Astrana Health

Intangibles To Total Assets

Astrana Health Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.66	0.94	0.72	0.97	0.99	0.52	0.81	0.93	0.93	0.22	0.96	1.0	0.18	0.89	0.97	0.3	0.93	0.93	0.35	0.77	0.89	0.9	0.9
Total Stockholder Equity	0.98		0.63	0.99	0.67	0.97	0.99	0.53	0.81	0.94	0.97	0.11	0.95	0.96	0.03	0.86	0.98	0.16	0.85	0.98	0.38	0.71	0.92	0.89	0.95
Net Debt	0.66	0.63		0.67	0.3	0.78	0.7	0.27	0.69	0.8	0.48	-0.01	0.83	0.65	0.25	0.68	0.51	0.13	0.52	0.6	0.48	0.27	0.65	0.55	0.59
Retained Earnings	0.94	0.99	0.67		0.6	0.96	0.96	0.53	0.8	0.95	0.94	0.0	0.95	0.92	-0.05	0.82	0.93	0.06	0.77	0.98	0.41	0.6	0.92	0.84	0.95
Accounts Payable	0.72	0.67	0.3	0.6		0.68	0.67	0.28	0.6	0.63	0.61	-0.04	0.6	0.76	0.0	0.49	0.69	0.02	0.82	0.61	0.25	0.65	0.53	0.48	0.55
Total Liab	0.97	0.97	0.78	0.96	0.68		0.99	0.49	0.84	0.98	0.9	0.08	0.99	0.97	0.1	0.86	0.92	0.18	0.86	0.93	0.42	0.67	0.9	0.85	0.9
Total Current Assets	0.99	0.99	0.7	0.96	0.67	0.99		0.52	0.82	0.95	0.93	0.19	0.98	0.98	0.17	0.9	0.97	0.26	0.89	0.95	0.37	0.73	0.91	0.91	0.92
Common Stock	0.52	0.53	0.27	0.53	0.28	0.49	0.52		0.39	0.44	0.53	0.11	0.49	0.51	0.12	0.52	0.55	0.1	0.46	0.53	0.29	0.21	0.6	0.59	0.58
Short Term Debt	0.81	0.81	0.69	0.8	0.6	0.84	0.82	0.39		0.76	0.74	0.08	0.84	0.8	0.23	0.82	0.79	0.16	0.72	0.8	0.77	0.55	0.79	0.73	0.75
Net Receivables	0.93	0.94	0.8	0.95	0.63	0.98	0.95	0.44	0.76		0.87	-0.01	0.96	0.93	-0.02	0.76	0.86	0.13	0.8	0.9	0.34	0.62	0.86	0.76	0.87
Net Tangible Assets	0.93	0.97	0.48	0.94	0.61	0.9	0.93	0.53	0.74	0.87		0.11	0.86	0.92	-0.07	0.79	0.96	0.21	0.81	0.96	0.32	0.74	0.87	0.85	0.91
Current Deferred Revenue	0.22	0.11	-0.01	0.0	-0.04	0.08	0.19	0.11	0.08	-0.01	0.11		0.13	0.21	0.71	0.37	0.24	0.72	0.32	0.0	-0.1	0.48	0.1	0.4	0.11
Long Term Debt	0.96	0.95	0.83	0.95	0.6	0.99	0.98	0.49	0.84	0.96	0.86	0.13		0.94	0.19	0.9	0.9	0.21	0.82	0.92	0.44	0.63	0.9	0.87	0.9
Good Will	1.0	0.96	0.65	0.92	0.76	0.97	0.98	0.51	0.8	0.93	0.92	0.21	0.94		0.18	0.86	0.96	0.32	0.95	0.91	0.35	0.78	0.86	0.87	0.87
Short Term Investments	0.18	0.03	0.25	-0.05	0.0	0.1	0.17	0.12	0.23	-0.02	-0.07	0.71	0.19	0.18		0.5	0.14	0.67	0.31	-0.03	0.16	0.19	0.09	0.39	0.01
Long Term Debt Total	0.89	0.86	0.68	0.82	0.49	0.86	0.9	0.52	0.82	0.76	0.79	0.37	0.9	0.86	0.5		0.88	0.37	0.79	0.84	0.45	0.62	0.84	0.95	0.84
Capital Surpluse	0.97	0.98	0.51	0.93	0.69	0.92	0.97	0.55	0.79	0.86	0.96	0.24	0.9	0.96	0.14	0.88		0.26	0.89	0.95	0.34	0.78	0.89	0.93	0.92
Deferred Long Term Liab	0.3	0.16	0.13	0.06	0.02	0.18	0.26	0.1	0.16	0.13	0.21	0.72	0.21	0.32	0.67	0.37	0.26		0.47	0.05	-0.09	0.49	0.08	0.37	0.03
Intangible Assets	0.93	0.85	0.52	0.77	0.82	0.86	0.89	0.46	0.72	0.8	0.81	0.32	0.82	0.95	0.31	0.79	0.89	0.47		0.76	0.28	0.82	0.73	0.79	0.72
Property Plant Equipment	0.93	0.98	0.6	0.98	0.61	0.93	0.95	0.53	0.8	0.9	0.96	0.0	0.92	0.91	-0.03	0.84	0.95	0.05	0.76		0.39	0.63	0.92	0.87	0.96
Short Long Term Debt	0.35	0.38	0.48	0.41	0.25	0.42	0.37	0.29	0.77	0.34	0.32	-0.1	0.44	0.35	0.16	0.45	0.34	-0.09	0.28	0.39		0.09	0.48	0.34	0.39
Long Term Investments	0.77	0.71	0.27	0.6	0.65	0.67	0.73	0.21	0.55	0.62	0.74	0.48	0.63	0.78	0.19	0.62	0.78	0.49	0.82	0.63	0.09		0.66	0.71	0.65
Net Invested Capital	0.89	0.92	0.65	0.92	0.53	0.9	0.91	0.6	0.79	0.86	0.87	0.1	0.9	0.86	0.09	0.84	0.89	0.08	0.73	0.92	0.48	0.66		0.9	0.97
Net Working Capital	0.9	0.89	0.55	0.84	0.48	0.85	0.91	0.59	0.73	0.76	0.85	0.4	0.87	0.87	0.39	0.95	0.93	0.37	0.79	0.87	0.34	0.71	0.9		0.9
Capital Stock	0.9	0.95	0.59	0.95	0.55	0.9	0.92	0.58	0.75	0.87	0.91	0.11	0.9	0.87	0.01	0.84	0.92	0.03	0.72	0.96	0.39	0.65	0.97	0.9

Click cells to compare fundamentals

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's Total Assets, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Total Assets	1.6 B	1.6 B
Intangibles To Total Assets	0.36	0.29

Currently Active Assets on Macroaxis

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill
CSAN	Cosan SA ADR
RKT	Rocket Companies

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.98)

Earnings Share

0.19

Revenue Per Share

59.463

Quarterly Revenue Growth

0.997

Return On Assets

0.0288

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Astrana Total Assets from 2010 to 2026

Latest Astrana Health's Total Assets Growth Pattern

Astrana Total Assets Regression Statistics

Astrana Total Assets History

Other Fundumenentals of Astrana Health

Astrana Health Total Assets component correlations

About Astrana Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY